Information Journal Paper
APA:
CopyRUIZ MILLO, O.. (2014). COMPARATIVE COST-EFFECTIVENESS OF BEVACIZUMAB-IRINOTECAN-FLUOROURACIL VERSUS IRINOTECAN-FLUOROURACIL IN FIRST-LINE METASTATIC COLORECTAL CANCER. JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 20(5), 341-350. SID. https://sid.ir/paper/665327/en
Vancouver:
CopyRUIZ MILLO O.. COMPARATIVE COST-EFFECTIVENESS OF BEVACIZUMAB-IRINOTECAN-FLUOROURACIL VERSUS IRINOTECAN-FLUOROURACIL IN FIRST-LINE METASTATIC COLORECTAL CANCER. JOURNAL OF ONCOLOGY PHARMACY PRACTICE[Internet]. 2014;20(5):341-350. Available from: https://sid.ir/paper/665327/en
IEEE:
CopyO. RUIZ MILLO, “COMPARATIVE COST-EFFECTIVENESS OF BEVACIZUMAB-IRINOTECAN-FLUOROURACIL VERSUS IRINOTECAN-FLUOROURACIL IN FIRST-LINE METASTATIC COLORECTAL CANCER,” JOURNAL OF ONCOLOGY PHARMACY PRACTICE, vol. 20, no. 5, pp. 341–350, 2014, [Online]. Available: https://sid.ir/paper/665327/en